Product Information |
DR-XY45842_PI_01.pdf
|
Registration Number |
DR-XY45842
|
Generic Name |
Ibrutinib
|
Brand Name |
Imbruvica
|
Dosage Strength |
140 mg
|
Dosage Form |
Capsule
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
-
|
Packaging |
HDPE Bottle x 90's (Box of 1's)
|
Manufacturer |
Catalent CTS, Inc.
|
Country of Origin |
United States of America
|
Trader |
N/A
|
Importer |
Johnson & Johnson (Phils.) Inc.
|
Distributor |
Johnson & Johnson (Phils.) Inc.
|
Application Type |
Monitored Release (Variation)
|
Issuance Date |
09 May 2023
|
Expiry Date |
09 May 2028
|